S&P 500 7,757.17 +0.58%
Nasdaq 26,702.86 +1.05%
S&P/TSX 36,324.99 +0.60%
Apple 343.99 +1.32%
Nvidia 221.97 +2.54%
Microsoft 532.95 +0.20%
Shopify 244.93 +0.38%
Royal Bank 283.62 +1.23%
CAD/USD 0.7129 +0.28%
CLOSED · 02:35 ET
Market ClerkRecap
Thu Oct 22 · markets closed2 signals on Oct 21108 insider buys this week · $250.3MCIRO short report next: Oct 30The week ahead
AB
INSIDER · KYMR · Kymera Therapeutics, Inc. · CHIEF LEGAL OFFICER

Adams Brian

Every open-market transaction filed under this name, Sep 4 to Sep 4.

Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$744K
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 4KYMRKymera Therapeutics, Inc.Chief Legal OfficerSell2,137$117.57$251K—
Sep 4KYMRKymera Therapeutics, Inc.Chief Legal OfficerSell3,025$116.81$353K—
Sep 4KYMRKymera Therapeutics, Inc.Chief Legal OfficerSell1,209$115.55$140K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.